Remove Biotech Remove Contract research organization Remove Ecosystems
article thumbnail

Are You Leveraging the Drug Discovery and Early Development Outsourcing Services Ecosystem to Accelerate Growth?

Frost & Sullivan

Growing demand for outsourcing, with contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) leading industry growth. How are drug discovery companies enhancing R&D and accelerating growth through ecosystem partnerships?

article thumbnail

How does your company’s benchmarking performance stack up against the leading precision health companies in the ecosystem?

Frost & Sullivan

Small- to mid-sized pharma/biotech players in APAC are rivaling Europe in clinical trials through multiple CRO partnerships in the region, tapping into a population-rich landscape. Let us coach you on your transformational journey, while we actively support you in fostering collaborative initiatives within your industry’s ecosystem.

article thumbnail

Transformational Growth Leadership: An Exclusive Interview with Yvonne Lungershausen, CEO, Avance Clinical

Frost & Sullivan

Innovating for Growth: The Future of Biotech CROs The biotech Contract Research Organization (CRO) industry is undergoing a rapid transformation, driven by technological advancements, globalization, and evolving patient needs. What are the top three trends you see driving change?

Biotech 52